Disruption of prostaglandin F2a receptor signaling attenuates fibrotic remodeling in a preclinical murine model of idiopathic pulmonary fibrosis
M. Beers (Philadelphia, United States), S. Tang (Philadelphia, United States), L. Rodriguez (Philadelphia, United States), Y. Tomer (Philadelphia, United States), A. Murthy (Philadelphia, United States), T. Cai (South San Francisco, United States), C. Connelly (South San Francisco, United States), A. Gillich (South San Francisco, United States), Y. Wong (South San Francisco, United States), G. Fitzgerald (Philadelphia, United States)
Source: International Congress 2022 – Molecular pathology and cellular biology of pulmonary diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Beers (Philadelphia, United States), S. Tang (Philadelphia, United States), L. Rodriguez (Philadelphia, United States), Y. Tomer (Philadelphia, United States), A. Murthy (Philadelphia, United States), T. Cai (South San Francisco, United States), C. Connelly (South San Francisco, United States), A. Gillich (South San Francisco, United States), Y. Wong (South San Francisco, United States), G. Fitzgerald (Philadelphia, United States). Disruption of prostaglandin F2a receptor signaling attenuates fibrotic remodeling in a preclinical murine model of idiopathic pulmonary fibrosis. 2081
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|